NCT04996875: (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- State
- Under way
- Phase
- Phase 2
- People
- 140 planned
- Started
- 9 Nov 2021
- Primary completion
- 19 Sep 2025
- Arms
- bezuclastinib
- Results
- None posted
- 9 Aug 2021: Trial registered
- 9 Nov 2021: Trial started